1. Home
  2. MLTX vs BOW Comparison

MLTX vs BOW Comparison

Compare MLTX & BOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$16.71

Market Cap

979.8M

Sector

Health Care

ML Signal

HOLD

Logo Bowhead Specialty Holdings Inc.

BOW

Bowhead Specialty Holdings Inc.

HOLD

Current Price

$23.96

Market Cap

913.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLTX
BOW
Founded
2021
2020
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
979.8M
913.3M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
MLTX
BOW
Price
$16.71
$23.96
Analyst Decision
Buy
Buy
Analyst Count
9
6
Target Price
$22.22
$35.00
AVG Volume (30 Days)
3.5M
180.4K
Earning Date
02-25-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
44.06
EPS
N/A
1.55
Revenue
N/A
$519,241,000.00
Revenue This Year
N/A
$16.05
Revenue Next Year
N/A
$25.43
P/E Ratio
N/A
$15.49
Revenue Growth
N/A
33.44
52 Week Low
$5.95
$23.50
52 Week High
$62.75
$42.29

Technical Indicators

Market Signals
Indicator
MLTX
BOW
Relative Strength Index (RSI) 59.35 33.21
Support Level $15.70 $28.12
Resistance Level $18.80 $25.72
Average True Range (ATR) 1.20 0.92
MACD 0.44 -0.36
Stochastic Oscillator 73.51 2.21

Price Performance

Historical Comparison
MLTX
BOW

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

About BOW Bowhead Specialty Holdings Inc.

Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity and hospitality segments and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.

Share on Social Networks: